Amarin Corp Plc (AMRN)

[Number sleven]

RMB, I'm going to ask you directly, what is the balance that Hatch Waxman claims to achieve? A skinny label takes the entire market. That isn't balance. FDA wants to protect ANDA labels from litigation. That pushes the scale even further away from balance. This could be what the Supreme Court wants to address.
Sleven,